Telcon RF Pharmaceutical Inc
KOSDAQ:200230
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Charter Communications Inc
LSE:0HW4
|
US |
Telcon RF Pharmaceutical Inc
Operating Expenses
Telcon RF Pharmaceutical Inc
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Telcon RF Pharmaceutical Inc
KOSDAQ:200230
|
Operating Expenses
-₩10.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
18%
|
CAGR 10-Years
-7%
|
|
|
D
|
DreamTech Co Ltd
KRX:192650
|
Operating Expenses
-₩99.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
K
|
KH Electron Co Ltd
KOSDAQ:111870
|
Operating Expenses
-₩5.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
18%
|
CAGR 10-Years
8%
|
|
|
P
|
Pavonine Co Ltd
KOSDAQ:177830
|
Operating Expenses
-₩13.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-9%
|
|
|
P
|
PJ Electronics Co Ltd
KOSDAQ:006140
|
Operating Expenses
-₩2.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-9%
|
|
Telcon RF Pharmaceutical Inc
Glance View
TELCON RF PHARMACEUTICAL.Inc. engages in the manufacture, development and sale of cable assemblies and medicinal products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2014-11-24. Inc., formerly TELCON.Inc, is a Korea-based company principally engaged in the manufacture and distribution of connectors and cable assemblies. The Company’s products mainly consist of radio frequency (RF) connectors, RF cables, couplers, dividers, arrestors, terminations, adapters, and other cable assemblies, which are used for wireless communication equipment.
See Also
What is Telcon RF Pharmaceutical Inc's Operating Expenses?
Operating Expenses
-10.5B
KRW
Based on the financial report for Sep 30, 2025, Telcon RF Pharmaceutical Inc's Operating Expenses amounts to -10.5B KRW.
What is Telcon RF Pharmaceutical Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-7%
Over the last year, the Operating Expenses growth was -6%.
